Medpace.com::Maximizing the Effectiveness of the Partnership with your CRO

Maximizing the Effectiveness of the Partnership with your CRO

Alita Hassan, MPH, BS
Director, Proposal Writing

Ms. Hassan has over 13 years clinical research experience, with therapeutic focus in anticoagulation, cardiovascular, lipid, and diabetes. She has chaired many discussions on clinical imaging and its use in clinical trials, and has managed steering committees and adjudication committees. She received her MPH with an emphasis in epidemiology and nutritional science from the University of Michigan and is currently working toward her PhD in epidemiology.

Additional Information

Experience has taught us that effective and consistent communication between the Sponsor, investigator and research sites, patients, and the Clinical Research Organization (CRO) is integral to the success of every clinical trial. It's a matter of how we think about drug development at Medpace – we recognize that development time is crucial and we believe that partnering leads to projects being delivered quickly, efficiently, and cost effectively.

Transcript (PDF)